Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
about
Pharmacotherapy of bipolar disorder in children and adolescents: an updateAripiprazole and Acute Extrapyramidal Symptoms in Children and Adolescents: A Meta-AnalysisDatabase analysis of children and adolescents with bipolar disorder consuming a micronutrient formula.Focus on aripiprazole: a review of its use in child and adolescent psychiatryEfficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic reviewObesity, serious mental illness and antipsychotic drugs.Issues in the management of patients with complex attention-deficit hyperactivity disorder symptoms.A Guide to Medications Inducing Salivary Gland Dysfunction, Xerostomia, and Subjective Sialorrhea: A Systematic Review Sponsored by the World Workshop on Oral Medicine VI.Pharmacotherapy of bipolar disorder in children and adolescents: recent progress.Psychopharmacology of pediatric bipolar disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.Diminished 5-HT functioning in CBCL pediatric bipolar disorder-profiled ADHD patients versus normal ADHD: susceptibility to rapid tryptophan depletion influences reaction time performance.Aripiprazole in Bipolar Disorder
P2860
Q27027052-A7C8DC25-D3F3-4407-B01F-2A77EC0BC7CBQ28073540-9D1D4033-5CDA-4A20-8538-36590EE4FA04Q34199313-7CC4D537-A837-4551-A473-75ACAD9BBE41Q34611306-16D81BF9-8073-4B97-BE68-ADF13E8702D5Q37299210-05DD141E-89A1-46B5-8FE8-0AE7D90CB5CBQ37498921-DEA38DD3-ED69-4C00-93AA-59E56B613C60Q37557589-64B2D4B9-7A1C-4E0E-AFE8-6725CE240E19Q37653402-2317FD03-90E9-4926-A5A2-D32528F0621DQ37742068-FB278C87-5FD3-4A86-906F-EB3A459DF591Q37768441-33FEB5C0-7C6B-47B1-B700-6C58E3E3AFAAQ45484599-ACEECBC7-2533-490C-8EAA-CAE7102B6B0FQ45990613-5A592222-5498-4F71-93C4-B0C320E91BCDQ46637334-24F05DED-19E1-4D4A-A7DB-9F68E008BCE7Q57612470-41C38062-1E3B-4677-A1F0-3B3534D36700
P2860
Aripiprazole in juvenile bipolar disorder comorbid with attention-deficit/hyperactivity disorder: an open clinical trial.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@en
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@nl
type
label
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@en
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@nl
prefLabel
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@en
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@nl
P2093
P2860
P1433
P1476
Aripiprazole in juvenile bipol ...... order: an open clinical trial.
@en
P2093
Carla Ketzer de Souza
Cristian Patrick Zeni
Gabriel Ferreira Pheula
Luis Augusto Rohde
Silza Tramontina
P2860
P304
P356
10.1017/S1092852900015443
P577
2007-10-01T00:00:00Z